Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-1448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Clinical Development of the E75 Vaccine in Breast Cancer

Breast Care
SurgeryOncology
2016English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials

Clinical Genitourinary Cancer
OncologyUrology
2014English

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials

Cancer
Cancer ResearchOncology
2010English

A Phase I Study of Cyclin-Dependent Kinase Inhibitor, AT7519, in Patients With Advanced Cancer: NCIC Clinical Trials Group IND 177

British Journal of Cancer
Cancer ResearchOncology
2014English

Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective

Canadian Urological Association Journal
Urology
2013English

P1.01-26 Single-Centre Experience of Clinical Outcomes for Advanced Lung Cancer Patients in Phase I Clinical Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase I Clinical Trial of a Peptide Vaccine Combined With Tegafur-Uracil Plus Leucovorin for Treatment of Advanced or Recurrent Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy